The Snowdome Foundation Research Impact Program supports research and clinical trials that accelerate new treatments for Australians with blood cancer. Priorities include genomics, precision medicine, targeted therapies and cellular therapies, with a clear pathway to patient benefit within three to five years.
Eligibility Criteria
- Individual researchers across early, mid and senior career stages may apply.
- Applicants must be Australian permanent residents or hold an appropriate Australian visa.
- Affiliation with a hospital or nonprofit institution is required.
- Applicants must demonstrate blood cancer research expertise appropriate to their career stage.
- Researchers without a substantial blood cancer track record must include an experienced co-principal investigator.
- Each principal investigator may submit only one application per round.
- Projects must demonstrate measurable milestones and a credible pathway to clinical translation.
Funding Details
- Funding available: Up to AUD $450,000 plus GST.
- Project duration: Up to three years.
- Eligible costs include project personnel, clinical trials, patient-related research, data analysis and specialised testing.
Deadline
- Expression of Interest: November 23, 2026, at midnight. The announcement does not specify a timezone.
- Outcomes are scheduled for February 2027.
Further Information
- Submit the official EOI template by email to grants@snowdome.org.au. Shortlisted applicants will be invited to submit a full application.
- Official announcement and application materials